Kara Hanson SD
- Kara Hanson's Contacts
- 15-17 Tavistock Place
- WC1H 9SH
- T: +44 20 7927 2267
- F: +44 20 020 7927 2701
My training is in development economics and health economics, and I have worked on health systems organisation and financing, mostly in sub-Saharan Africa, since 1988. I did my doctorate at the Harvard School of Public Health, and joined LSHTM in 1997.
I teach Introduction to Health Economics (Term 1), and tutor on the MSc in Public Health in Developing Countries. My research degrees students are studying topics including human resources in Malawi, approaches to measuring progress towards Universal Health Coverage, and the demand for antimalarial medicines.
My research has focused primarily on the economics of health systems in low- and middle-income countries. I have done research on hospital sector reforms in Uganda and Zambia, focusing on the implications of two-tier pricing for equity of access to hospital services. I am interested in the role of the private sector in health systems, and in identifying the opportunities and limitations of the private sector in improving the efficiency, quality and responsiveness of health systems. I work with a DFID funded project on education systems research, contributing insights from the development of health systems research methods. I am co-Research Director of RESYST - Resilient and Responsive Health Systems, which is a UK-DFID funded research consortium bringing together researchers from South Africa, Nigeria, Kenya, Tanzania, Thailand, India, Vietnam and the UK (http://resyst.lshtm.ac.uk). Our programme includes research on health financing, health workers and governance and leadership in the health sector.
My second area of focus is the economics of malaria control interventions. In particular, I am interested in understanding better how to expand access to interventions that have been shown to be cost-effective. Recent activities in this area include the ACTWatch Project, studying the market for antimalarial medicines (www.actwatch.info) and a linked grant from the ESRC Secondary Data Analysis Initiative to estimate the demand for antimalarials; and economic evaluations of a range of interventions addressing malaria in pregnancy (http://www.mip-consortium.org); and the Independent Evaluation of the Affordable Medicines Facility-malaria, which is an innovative financing mechanism for antimalarial drugs (http://www.theglobalfund.org/en/amfm/).
I am a member of the Centre for Evaluation (http://evaluation.lshtm.ac.uk/), the Malaria Centre (http://malaria.lshtm.ac.uk), and the Centre for Global Noncommunicable Diseases (http://globalncds.lshtm.ac.uk).
In January 2015 I was appointed Associate Dean for Research in the Faculty of Public Health and Policy.
- Complex interventions
- Economic evaluation
- Health care financing
- Health policy
- Health sector development
- Health services research
- Health systems
- Health workers
- Private sector
Disease and Health Conditions
- Access To Medicines
- Health Economics
- Hospital Reform
Cost-effectiveness of two versus three or more doses of intermittent preventive treatment for malaria during pregnancy in sub-Saharan Africa: a modelling study of meta-analysis and cost data.
Fernandes, S. ; Sicuri, E. ; Kayentao, K. ; van Eijk, A.M. ; Hill, J. ; Webster, J. ; Were, V. ; Akazili, J. ; Madanitsa, M. ; Ter Kuile, F.O. ; Hanson, K. ;
Lancet Glob Health, 2015; 3(3):e143-53
Going beyond horizontal equity: An analysis of health expenditure allocation across geographic areas in Mozambique.
Anselmi, L. ; Lagarde, M. ; Hanson, K. ;
Soc Sci Med, 2015; 130C:216-224
Who benefits from free healthcare? Evidence from a randomized experiment in Ghana
Powell-Jackson, T.; Hanson, K.; Whitty, C.J.M.; Ansah, E.K.
Journal of Development Economics, 2014; 107(0):305-319
Institutional Solutions to the Asymmetric Information Problem in Health and Development Services for the Poor
Leonard, D. K.; Bloom, G.; Hanson, K.; O'Farrell, J.; Spicer, N.
World Development, 2013; 48:71-87
Donor funding for newborn survival: an analysis of donor-reported data, 2002-2010.
Pitt, C. ; Lawn, J.E. ; Ranganathan, M. ; Mills, A. ; Hanson, K. ;
PLoS Med, 2012; 9(10):e1001332
Effect of the Affordable Medicines Facility-malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey data.
Tougher, S.; ACTwatch Group (inc; Palafox, B.;) Ye, Y.; Amuasi, J.H.; Kourgueni, I.A.; Thomson, R.; Goodman, C.; Mann, A.G.; Ren, R.; Willey, B.A.; Adegoke, C.A.; Amin, A.; Ansong, D.; Bruxvoort, K.; Diallo, D.A.; Diap, G.; Festo, C.; Johanes, B.; Juma, E.; Kalolella, A.; Malam, O.; Mberu, B.; Ndiaye, S.; Nguah, S.B.; Seydou, M.; Taylor, M.; Rueda, S.T.; Wamukoya, M.; Arnold, F.; Hanson, K.;
Lancet, 2012; 380(9857):1916-26
Building the field of health policy and systems research: framing the questions.
Sheikh, K. ; Gilson, L. ; Agyepong, I.A. ; Hanson, K. ; Ssengooba, F. ; Bennett, S. ;
PLoS Med, 2011; 8(8):e1001073
- → View all Kara Hanson's publications